Robert J. Israel

progen pharmaceuticals inc.

24H指数

133论文数

2.8K被引数

收录论文 28

发表时间

Mucosal improvement and histologic healing with amiselimod for active Ulcerative Colitis: a phase 2, randomised, placebo-controlled trial

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-22

PREAI

Schreiber, S. W.; Laitman, A. P.; Heimanson, Z.; Israel, R. J.; Lee, J.; Hanauer, S. B.

The Sphingosine 1-Phosphate Receptor Modulator Amiselimod is Efficacious for the Treatment of Active Ulcerative Colitis: Results from a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial 鞘氨醇1-磷酸受体调节剂Amiselimod对活动性溃疡性结肠炎的治疗有效：一项2期随机、双盲、安慰剂对照试验的结果

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2024-12-01

OAAI

Hanauer, SB; Laitman, AP; Heimanson, Z; Israel, RJ; Lee, JM; Schreiber, S

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials 利福昔明可溶性固体分散体片治疗成人肝硬化的剂量: 2项随机，安慰剂对照试验

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2023-03-01

PREAI

Bajaj, Jasmohan S.; Hassanein, Tarek I.; Pyrsopoulos, Nikolaos T.; Sanyal, Arun J.; Rahimi, Robert S.; Heimanson, Zeev; Israel, Robert J.; Rockey, Don C.

Efficacy of rifaximin soluble solid dispersion in patients with early decompensated cirrhosis and a Conn score of 0: A post hoc analysis of a randomized, double-blind, placebo-controlled trial

JOURNAL OF HEPATOLOGY

IF33

2019-04-01

PREAI

Bajaj, Jasmohan S.; Heimanson, Zeev; Israel, Robert; Sanyal, Arun

Efficacy Variables in Cancer Versus Noncancer Patients Treated with Methylnaltrexone or Placebo: An Analysis of 2 Placebo-Controlled Studies

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2019-02-01

OAAI

Chamberlain, Bruce; Rhiner, Michelle; Slatkin, Neal; Stambler, Nancy; Israel, Robert

Treatment with Methylnaltrexone in Patients with Opioid-Induced Constipation with or Without Active Cancer

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2019-02-01

PREAI

Chamberlain, Bruce; Rhiner, Michelle; Slatkin, Neal; Stambler, Nancy; Israel, Robert

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome

GUT MICROBES

IF11

2018-07-18

OAAI

Fodor, Anthony A.; Pimentel, Mark; Chey, William D.; Lembo, Anthony; Golden, Pamela L.; Israel, Robert J.; Carroll, Ian M.

Lactulose Breath Testing Predicts the Response to Rifaximin

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2017-10-01

PREAI

Rezaie, Ali; Heimanson, Zeev; Israel, Robert; Pimentel, Mark

Oral methylnaltrexone for adults with chronic noncancer pain and opioid-induced constipation (OIC): timing and characterization of clinical symptoms do not suggest opioid withdrawal with daily treatment

JOURNAL OF PAIN

IF4

2017-04-01

OAAI

Rauck, R.; Slatkin, N.; Harper, J.; Israel, R.

Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2017-01-01

OAAI

DuPont, Herbert L.; Wolf, Ray A.; Israel, Robert J.; Pimentel, Mark

Androgen receptor (AR) and AR-V7 expression in circulating tumor cells (CTCs) and response to prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in castration-resistant prostate cancer: A correlative analysis from a phase 2 trial

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Petrylak, D. P.; DiPippo, V. A.; Werner, S. L.; Baird, S.; Anderson, A. K. L.; Marrinucci, D.; Israel, R. J.

PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN PATIENTS (PTS) WITH PROGRESSIVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) FOLLOWING ABIRATERONE AND/OR ENZALUTAMIDE (ABI/ENZ): RESULTS FROM A PHASE 2 STUDY

JOURNAL OF UROLOGY

IF6.8

2015-04-01

PREAI

Petrylak, Daniel; Vogelzang, Nicholas; Chatta, Kamal; Fleming, Mark; Smith, David; Appleman, Leonard; Hussain, Arif; Modiano, Manuel; Singh, Parminder; Tagawa, Scott; Gore, Ira; McClay, Ed; Mega, Anthony; Sartor, Oliver; Somer, Brad; Wadlow, Raymond; Shore, Neal; Stambler, Nancy; DiPippo, Vincent; Israel, Robert

A PHASE 2 TRIAL OF PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN TAXANE-TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)

JOURNAL OF UROLOGY

IF6.8

2014-04-01

PREAI

Petrylak, Daniel; Smith, David C.; Appleman, Leonard J.; Fleming, Mark; Hussain, Arif; Dreicer, Robert; Sartor, A. Oliver; Shore, Neil; Vogelzang, Nicholas J.; Youssoufian, Hagop; Olson, William; Stambler, Nancy; Huang, Kathleen; Israel, Robert

Correlation of PSMA ADC exposure with reduction in tumor growth rate determined using serial PSA measurements from a Phase I clinical trial.

MOLECULAR CANCER THERAPEUTICS

IF5.5

2013-11-01

PREAI

Rotshteyn, Yakov; Mercier, F.; Bruno, R.; Stambler, Nancy; Israel, Robert J.; Wong, Vivien

Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)

EUROPEAN JOURNAL OF CANCER

IF7.1

2012-11-01

PREAI

Petrylak, D.; Kantoff, P.; Mega, A.; Stephenson, J.; Vogelzang, N.; Fleming, M.; Blattman, S.; Stambler, N.; D'Ambrosio, P.; Israel, R. J.

Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2011-11-01

OAAI

Slatkin, Neal E.; Lynn, Richard; Su, Chinyu; Wang, Wenjin; Israel, Robert J.

Methylnaltrexone Treatment of Opioid-Induced Constipation in Patients with Advanced Illness

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2009-11-01

OAAI

Chamberlain, Bruce H.; Cross, Karen; Winston, Jaron L.; Thomas, Jay; Wang, Wenjin; Su, Chinyu; Israel, Robert J.

Methylnaltrexone for opioid-induced constipation in advanced illness

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2008-05-29

406

OAAI

Thomas, Jay; Karver, Sloan; Cooney, Gail Austin; Chamberlain, Bruce H.; Watt, Charles Kevin; Slatkin, Neal E.; Stambler, Nancy; Kremer, Alton B.; Israel, Robert J.

Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: A double-blind, randomized, parallel group, dose-ranging study

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

IF3.5

2008-05-01

126

OAAI

Portenoy, Russell K.; Thomas, Jay; Boatwright, Michele L. Moehl; Tran, Diep; Galasso, Frank L.; Stambler, Nancy; Von Gunten, Charles F.; Israel, Robert J.

Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2007-03-28

PREAI

Rosow, C. E.; Gomery, P.; Chen, T. Y.; Stefanovich, P.; Stambler, N.; Israel, R.

研究方向